LOXL3 and invasive ductal breast carcinoma: Koorman T et al. utilized immunofluorescence techniques to explore the localization of LOXL3, and they reported predominant expression of LOXL3 in surrounding myoepithelial cells in normal human breast tissue and invasive ductal carcinoma no special type (IDCNST), with minimal expression in the cancer cells themselves, highlighting the role of LOXL3 in promoting the collective invasion of ductal breast cancer cells into the collagen matrix through its involvement in collagen remodelling processes.